Novo Nordisk
NVO
#21
Rank
ยฃ362.16 B
Marketcap
ยฃ83.33
Share price
2.57%
Change (1 day)
0.63%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2024 (TTM): ยฃ13.43 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are ยฃ37.32 Billion. In 2023 the company made an earning of ยฃ12.21 Billion, an increase over its 2022 earnings that were of ยฃ7.74 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) ยฃ13.43 B9.99%
2023 ยฃ12.21 B57.64%
2022 ยฃ7.74 B5.35%
2021 ยฃ7.35 B12.47%
2020 ยฃ6.53 B13.07%
2019 ยฃ5.78 B-3.35%
2018 ยฃ5.98 B1.79%
2017 ยฃ5.87 B4.52%
2016 ยฃ5.62 B9.42%
2015 ยฃ5.13 B8.24%
2014 ยฃ4.74 B3.45%
2013 ยฃ4.59 B19.02%
2012 ยฃ3.85 B15.21%
2011 ยฃ3.34 B17.71%
2010 ยฃ2.84 B24.78%
2009 ยฃ2.27 B10.62%
2008 ยฃ2.06 B55.97%
2007 ยฃ1.32 B7.07%
2006 ยฃ1.23 B18.18%
2005 ยฃ1.04 B11.33%
2004 ยฃ0.93 B
2002 ยฃ0.59 B-14.39%
2001 ยฃ0.69 B-52.82%
2000 ยฃ1.47 B250%
1999 ยฃ0.42 B31.21%
1998 ยฃ0.32 B34.31%
1997 ยฃ0.23 B11.46%
1996 ยฃ0.21 B9.03%
1995 ยฃ0.19 B-3.15%
1994 ยฃ0.20 B-0.67%
1993 ยฃ0.20 B45.38%
1992 ยฃ0.14 B-13.81%
1991 ยฃ0.16 B37.12%
1990 ยฃ0.11 B-0.79%
1989 ยฃ0.12 B26.2%
1988 ยฃ95.26 M24.97%
1987 ยฃ76.23 M-0.9%
1986 ยฃ76.92 M-7.78%
1985 ยฃ83.42 M24.87%
1984 ยฃ66.8 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-ยฃ0.96 Billion-107.19%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ8.03 B-39.77%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ5.45 Billion-140.82%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ5.86 B-56.04%๐Ÿ‡ซ๐Ÿ‡ท France